Pharmaceutical Patent Term Extension

March 27, 2019

A period of market exclusivity is critical for most novel pharmaceutical products and the duration of that exclusivity has a direct impact on the value of a pharmaceutical asset. There several forms of exclusivity that can apply to pharmaceutical products. This overview is a summary of one of them: the patent term adjustment.

Spotlight

Qualitas Health Australia

Qualitas Healthcare Australia (Qualitas Health) is the Australian subsidiary of the Qualitas Medical Group, which is one of the largest integrated networks of general practice, allied health and specialist clinics in the world, with more than 250 medical centres across South East Asia, India and the Asia Pacific region. Headquartered in North Sydney, Qualitas Health began operations in Australia in late 2010, and have since integrated GP and Radiology clinics across New South Wales, Victoria and Queensland into its network.

OTHER WHITEPAPERS
news image

Characterization of Protein Aggregates and Other Particles in Biopharmaceuticals

whitePaper | July 8, 2022

Particulates are ubiquitous in parenteral drug products and remain a concern throughout their development and production1–3. These particles must be monitored to satisfy.

Read More
news image

Overcoming technical challenges in cell-based high throughput screens

whitePaper | November 11, 2022

Tremendous technological advancements in automated biotechnology and combinatorial chemistry have led to the widespread implementation of high throughput screening (HTS) for drug discovery since the early 1990s.

Read More
news image

MOLECULAR GLUES LANDSCAPE IN DRUG DISCOVERY

whitePaper | June 21, 2022

nduced-proximity targeted protein degradation (TPD) is a ground-breaking strategy in drug discovery that has emerged during the last decade.

Read More
news image

Using High Throughput SPR to Explore the Full Kinetic and Epitope Diversity of Large Antibody Libraries

whitePaper | February 24, 2023

A new way of thinking and working has evolved for the discovery of therapeutic antibodies. Until recently, large numbers of antibodies were generated, only for a relatively small fraction to be sampled and engineered for further lead generation.

Read More
news image

Combatting Future Viral Threats with Vaccine Advances

whitePaper | February 3, 2023

Since the beginning of the COVID-19 pandemic, pharmaceutical organizations have experienced major changes, a prime example of which has been the rising requirement for collaborations on multiple different fronts across the industry.

Read More
news image

Best Practices for RIM Business Process Automation

whitePaper | December 29, 2022

Regulatory teams at life science companies are finding that effective regulatory information management (RIM) has become critical to their operations.

Read More

Spotlight

Qualitas Health Australia

Qualitas Healthcare Australia (Qualitas Health) is the Australian subsidiary of the Qualitas Medical Group, which is one of the largest integrated networks of general practice, allied health and specialist clinics in the world, with more than 250 medical centres across South East Asia, India and the Asia Pacific region. Headquartered in North Sydney, Qualitas Health began operations in Australia in late 2010, and have since integrated GP and Radiology clinics across New South Wales, Victoria and Queensland into its network.

Events